Circulatory assist devices 2000: An update

Congestive Heart Failure

Volumn 6, Issue 5, 2000, Pages 259-271

  Dyke, D B S ^a   Pagani, F D ^a   Aaronson, K D ^a  

^a Department of Internal Medicine Ann Arbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; AORTA BALLOON; ARTIFICIAL HEART; ASSISTED CIRCULATION; COUNTERPULSATION; EXTRACORPOREAL CIRCULATION; HEART ARRHYTHMIA; HEART DILATATION; HEART INFARCTION; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; INFECTION; MYOCARDITIS; PULMONARY HYPERTENSION; REVIEW; TRANSPLANTATION;

EID: 0034426756     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2000.80165.x     Document Type: Review

References (59)

1. A double perfusion pump
2. A simple continuous flow blood transfusion instrument
3. The artificial heart
4. Application of a mechanical heart and lung apparatus to cardiac surgery
5. Permanent substitutes for valves and hearts
6. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock
7. Orthotopic cardiac prosthesis for two-staged cardiac replacement
8. Clinical use of the total artificial heart
9. Implantable left ventricular assist devices
10. The REMATCH trial: Rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure
11. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation
12. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization
13. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology
14. Improved survival after extended bridge to cardiac transplantation
15. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices
16. Mechanical ventricular assistance: An economical and effective means of treating end-stage heart disease
17. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: Safe, economical, necessary
18. Evolving costs of long-term left ventricular assist device implantation
19. Atrial balloon septostomy in the management and prevention of pulmonary hemorrhage in patients requiring extracorporeal life support
20. Worldwide experience with the TCI HeartMate system: Issues and future perspective
21. Artificial circulatory support with textured interior surfaces: A counterintuitive approach to minimizing thromboembolism
22. Success rates of longterm circulatory assist devices used currently for bridge to heart transplantation
23. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
24. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance
25. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
26. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices
27. Frequency and significance of infections in patients receiving prolonged LVAD support
28. Successful bridge to heart transplantation with a new left ventricular assist device
29. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival
30. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices
31. Prevention of bacterial endocarditis
32. Influence of panelreactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation
33. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support
34. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization
35. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: Risk factors and treatment
36. Development of anti-major histocompatibility complex class I or II antibodies following LVAD implant: Effects on subsequent allograft rejection and survival
37. Thromboembolic complications of the Symbion AVAD System
38. Thromboembolic complications of the Jarvik-7 total artificial heart: Case report
39. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients
40. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation
41. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival
42. Mechanical circulatory support with the Novacor LVAS: World-wide clinical results
43. Reduction of embolic complications in left ventricular assist systems (LVAS) recipients: Impact of inflow conduit design
44. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitie Hospital with patients on total artificial heart
45. Summary of the clinical use of the Symbion total artificial heart: A registry report
46. The CardioWest total artificial heart bridge to transplantation: 1993 to 1996 national trial
47. Arizona experience with Cardio-West total artificial heart bridge to transplantation
48. Bridge-to-transplant (BTT) experience with the Novacor Left Ventricular Assist System (LVAS): Results of a multicenter study
49. Success rates of longterm circulatory assist devices used currently for bridge to transplantation
50. Improved left ventricular function after chronic left ventricular unloading
51. Myocyte recovery after mechanical circulatory support in humans with endstage heart failure
52. Neurohormonal changes after implantation of a left ventricular assist system
53. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
54. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
55. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation
56. Jarvik 2000 heart: Potential for bridge to myocyte recovery